Parkinson's disease is a neurodegenerative disorder characterized by uncontrollable movements, stiffness, and cognitive decline. Curious? Come learn more!
Â
Please rate, review, and subscribe and if you have any questions, comments, concerns, queries, or complaints, please email me at
[email protected] or DM me at NeuroscienceAmateurHour on Instagram.
Also if you have the means/desire to financially support this podcast - please go to https://www.buymeacoffee.com/neuroscience
I really appreciate it!!!
Citations and relevant papers are below.
National Institute on Aging. Parkinsonâs Disease: Causes, Symptoms, and Treatments. National Institute on Aging.Â
Hogg E, Frank S, Oft J, Benway B, Rashid MH, Lahiri S. Urinary Tract Infection in Parkinsonâs Disease. Journal of Parkinsonâs Disease. 2022;12(3):743-757.Â
âYu J. Stages of Parkinsonâs | Parkinsonâs Foundation. www.parkinson.org. Published 2022.Â
âZhang ZX, Dong ZH, Román GC. Early Descriptions of Parkinson Disease in Ancient China. Archives of Neurology. 2006;63(5):782.Â
â2-Minute Neuroscience: Direct Pathway of the Basal Ganglia. www.youtube.com.Â
2-Minute Neuroscience: Indirect Pathway of the Basal Ganglia. www.youtube.com.Â
âThanvi B, Lo N, Robinson T. Levodopa-induced dyskinesia in Parkinsonâs disease: clinical features, pathogenesis, prevention and treatment. Postgraduate Medical Journal. 2007;83(980):384-388.Â
Zhang JF, Wang XX, Feng Y, Fekete R, Jankovic J, Wu YC. Impulse Control Disorders in Parkinsonâs Disease: Epidemiology, Pathogenesis and Therapeutic Strategies. Frontiers in Psychiatry. 2021;12.Â
Hisahara S, Shimohama S. Dopamine Receptors and Parkinsonâs Disease. International Journal of Medicinal Chemistry. 2011;2011:1-16.Â
Houston. Tmc.edu. Published October 20, 2020. https://nba.uth.tmc.edu/neuroscience/m/s3/chapter04.html
âOvallath S, Sulthana B. Levodopa: History and Therapeutic Applications. Annals of Indian Academy of Neurology. 2017;20(3):185-189.Â
âLevodopa | Parkinsonâs Foundation. www.parkinson.org. https://www.parkinson.org/living-with-parkinsons/treatment/prescription-medications/levodopa
âKelly MJ, Baig F, Hu MTM, Okai D. Spectrum of impulse control behaviours in Parkinsonâs disease: pathophysiology and management. Journal of Neurology, Neurosurgery & Psychiatry. 2020;91(7):703-711.Â
âGerfen CR, Surmeier DJ. Modulation of Striatal Projection Systems by Dopamine. Annual Review of Neuroscience. 2011;34(1):441-466.Â
âSayare S. The Woman Who Could Smell Parkinsonâs. The New York Times. https://www.nytimes.com/2024/06/14/magazine/parkinsons-smell-disease-detection.html. Published June 14, 2024.Â
âBlandini F, Nappi G, Tassorelli C, Martignoni E. Functional changes of the basal ganglia circuitry in Parkinsonâs disease. Progress in Neurobiology. 2000;62(1):63-88.Â
âLanciego JL, Luquin N, Obeso JA. Functional Neuroanatomy of the Basal Ganglia. Cold Spring Harbor Perspectives in Medicine. 2012;2(12):a009621-a009621.Â
Support the show